NYSE:MD (USA) Also trade in: Germany Mexico

Mednax Inc

$ 25.78 0.08 (0.31%)
On watch
Volume: 672,247 Avg Vol (1m): 1,040,974
Market Cap $: 2.23 Bil Enterprise Value $: 4.24 Bil
P/E (TTM): 9.43 P/B: 0.80
Earnings Power Value 28.02
Net Current Asset Value -21.6
Tangible Book -18.33
Projected FCF 80.69
Median P/S Value 82.85
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 40.51
DCF (Earnings Based) 34.93
1Y (-%)

Financial Strength : 5/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.05
Cash-To-Debt ranked lower than
88.32% of 274 companies
in the Medical Care industry.
Industry Max: 10000, Med: 0.28, Min: 0.01
MD: 0.05
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.01, Med: 0.31, Max: 312.43
Current: 0.05
0.01
312.43
Equity-to-Asset 0.49
Equity-to-Asset ranked higher than
57.99% of 269 companies
in the Medical Care industry.
Industry Max: 0.97, Med: 0.48, Min: -15.93
MD: 0.49
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: 0.49, Med: 0.76, Max: 0.91
Current: 0.49
0.49
0.91
Debt-to-Equity 0.76
Debt-to-Equity ranked higher than
53.96% of 202 companies
in the Medical Care industry.
Industry Max: 25.64, Med: 0.64, Min: 0.01
MD: 0.76
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: 0, Med: 0.06, Max: 0.76
Current: 0.76
0
0.76
Debt-to-EBITDA 3.90
Debt-to-EBITDA ranked lower than
54.23% of 201 companies
in the Medical Care industry.
Industry Max: 66.84, Med: 2.81, Min: 0.01
MD: 3.9
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: 0.06, Med: 0.72, Max: 3.9
Current: 3.9
0.06
3.9
Interest Coverage 4.22
Interest Coverage ranked lower than
51.10% of 227 companies
in the Medical Care industry.
Industry Max: 48765, Med: 6.85, Min: 0.01
MD: 4.22
Ranked among companies with meaningful Interest Coverage only.
Interest Coverage range over the past 10 years
Min: 4.22, Med: 70.6, Max: 120.04
Current: 4.22
4.22
120.04
Piotroski F-Score 4
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.91
DISTRESS
GREY
SAFE
Beneish M-Score -2.90
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 6.28%
WACC 6.33%

Profitability & Growth : 8/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 11.67
Operating Margin ranked higher than
72.06% of 272 companies
in the Medical Care industry.
Industry Max: 66.83, Med: 6.83, Min: -3742
MD: 11.67
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: 11.67, Med: 21.01, Max: 22.43
Current: 11.67
11.67
22.43
Net Margin % -1.05
Net Margin ranked higher than
73.90% of 272 companies
in the Medical Care industry.
Industry Max: 202.55, Med: 3.88, Min: -4897.7
MD: -1.05
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -1.05, Med: 13.02, Max: 14.46
Current: -1.05
-1.05
14.46
ROE % -1.24
ROE ranked higher than
63.14% of 255 companies
in the Medical Care industry.
Industry Max: 73.04, Med: 8.03, Min: -4811.69
MD: -1.24
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: -1.24, Med: 13.27, Max: 16.31
Current: -1.24
-1.24
16.31
ROA % -0.64
ROA ranked higher than
66.67% of 273 companies
in the Medical Care industry.
Industry Max: 52.42, Med: 3.48, Min: -3383.78
MD: -0.64
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -0.64, Med: 9.59, Max: 11.04
Current: -0.64
-0.64
11.04
ROC (Joel Greenblatt) % 121.85
ROC (Joel Greenblatt) ranked higher than
94.12% of 272 companies
in the Medical Care industry.
Industry Max: 8470.37, Med: 14.91, Min: -33236.56
MD: 121.85
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: 121.85, Med: 461.47, Max: 755.09
Current: 121.85
121.85
755.09
3-Year Total Revenue Growth Rate 9.50
3-Year Revenue Growth Rate ranked higher than
77.25% of 211 companies
in the Medical Care industry.
Industry Max: 314.7, Med: 6.5, Min: -100
MD: 10.4
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: -7.6, Med: 14.8, Max: 72.8
Current: 10.4
-7.6
72.8
3-Year Total EBITDA Growth Rate -3.20
3-Year EBITDA Growth Rate ranked lower than
57.07% of 184 companies
in the Medical Care industry.
Industry Max: 236.4, Med: 5.9, Min: -108
MD: -2.4
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
3-Year EBITDA Growth Rate range over the past 10 years
Min: -10.5, Med: 13.2, Max: 68.7
Current: -2.4
-10.5
68.7
3-Year EPS w/o NRI Growth Rate -6.50
3-Year EPS w/o NRI Growth Rate ranked lower than
60.49% of 162 companies
in the Medical Care industry.
Industry Max: 136.6, Med: 8.4, Min: -146.6
MD: -6.5
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: -11.6, Med: 14.05, Max: 85
Current: -6.5
-11.6
85

» MD's 30-Y Financials

Financials (Next Earnings Date: 2019-08-02)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:MD

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Health Care Providers » Medical Care    NAICS : 621498    SIC : 8093
Compare NYSE:THC SAU:4002 NYSE:AMN NSE:APOLLOHOSP JSE:LHC XSGO:BANMEDICA NYSE:SEM NAS:LPNT XTER:RHK ISX:MIKA JSE:NTC TSE:7716 NAS:ACHC ASX:HSO LSE:MDC BKK:SVH-F NYSE:USPH OTCPK:BLSTF BOM:532843 SGX:BSL
Traded in other countries PDC.Germany
Address 1301 Concord Terrace, Sunrise, FL, USA, 33323
Mednax Inc provides physician services, which include newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology, and other pediatric subspecialty care. The firm operates in six segments: neonatal and other pediatric subspecialties, anesthesia, maternal-fetal, pediatric cardiology, radiology, and other services. The neonatal segment contributes the largest proportion of the firm's revenue. Mednax generates virtually all of its revenue in the United States, with over half of its revenue from operations in five states: Texas, North Carolina, Georgia, Tennessee, and Florida. Contracted managed care payors contribute the majority of net collections.

Ratios

Current vs industry vs history
Forward PE Ratio 7.39
Forward P/E ranked lower than
100.00% of 59 companies
in the Medical Care industry.
Industry Max: 107.53, Med: 20.66, Min: 8.31
MD: 7.39
Ranked among companies with meaningful Forward P/E only.
N/A
PE Ratio without NRI 9.43
PE without NRI ranked higher than
78.79% of 198 companies
in the Medical Care industry.
Industry Max: 6430, Med: 9999, Min: 1.39
MD: 9.43
Ranked among companies with meaningful PE without NRI only.
PE without NRI range over the past 10 years
Min: 8.03, Med: 16.02, Max: 25.12
Current: 9.43
8.03
25.12
PB Ratio 0.80
PB Ratio ranked higher than
68.77% of 253 companies
in the Medical Care industry.
Industry Max: 48, Med: 2.64, Min: 0.05
MD: 0.8
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 0.77, Med: 2.12, Max: 3.59
Current: 0.8
0.77
3.59
PS Ratio 0.64
PS Ratio ranked higher than
54.96% of 262 companies
in the Medical Care industry.
Industry Max: 79.41, Med: 1.7, Min: 0.03
MD: 0.64
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 0.62, Med: 2.07, Max: 3.16
Current: 0.64
0.62
3.16
Price-to-Free-Cash-Flow 7.89
Price-to-Free-Cash-Flow ranked higher than
83.70% of 135 companies
in the Medical Care industry.
Industry Max: 777.22, Med: 23.01, Min: 1.25
MD: 7.89
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
Price-to-Free-Cash-Flow range over the past 10 years
Min: 6.34, Med: 13.64, Max: 20.36
Current: 7.89
6.34
20.36
Price-to-Operating-Cash-Flow 6.82
Price-to-Operating-Cash-Flow ranked higher than
64.52% of 186 companies
in the Medical Care industry.
Industry Max: 1706.9, Med: 14.67, Min: 0.7
MD: 6.82
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 5.83, Med: 12.56, Max: 19.25
Current: 6.82
5.83
19.25
EV-to-EBIT 9.82
EV-to-EBIT ranked higher than
76.64% of 214 companies
in the Medical Care industry.
Industry Max: 3101.61, Med: 21.68, Min: 1.06
MD: 9.82
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: 5.2, Med: 11.4, Max: 16.9
Current: 9.82
5.2
16.9
EV-to-EBITDA 7.79
EV-to-EBITDA ranked higher than
66.23% of 228 companies
in the Medical Care industry.
Industry Max: 1827.89, Med: 15.23, Min: 0.9
MD: 7.79
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: 4.9, Med: 10.1, Max: 15.4
Current: 7.79
4.9
15.4
EV-to-Revenue 1.18
EV-to-Revenue ranked higher than
51.66% of 271 companies
in the Medical Care industry.
Industry Max: 158.19, Med: 2.17, Min: 0.06
MD: 1.18
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 1.2, Med: 2.2, Max: 3.5
Current: 1.18
1.2
3.5
PEG Ratio 2.00
PEG Ratio ranked higher than
72.16% of 97 companies
in the Medical Care industry.
Industry Max: 497.4, Med: 3.13, Min: 0.11
MD: 2
Ranked among companies with meaningful PEG Ratio only.
PEG Ratio range over the past 10 years
Min: 0.36, Med: 1.35, Max: 3.82
Current: 2
0.36
3.82
Shiller PE Ratio 9.48
Shiller PE Ratio ranked higher than
77.42% of 62 companies
in the Medical Care industry.
Industry Max: 1305.92, Med: 31.76, Min: 8.18
MD: 9.48
Ranked among companies with meaningful Shiller PE Ratio only.
Shiller PE Ratio range over the past 10 years
Min: 9.07, Med: 25.32, Max: 38.13
Current: 9.48
9.07
38.13
Current Ratio 2.55
Current Ratio ranked lower than
58.08% of 260 companies
in the Medical Care industry.
Industry Max: 13.59, Med: 1.34, Min: 0.04
MD: 2.55
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 0.77, Med: 1.41, Max: 11.34
Current: 2.55
0.77
11.34
Quick Ratio 2.55
Quick Ratio ranked lower than
52.31% of 260 companies
in the Medical Care industry.
Industry Max: 13.59, Med: 1.24, Min: 0.04
MD: 2.55
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.77, Med: 1.41, Max: 11.34
Current: 2.55
0.77
11.34
Days Sales Outstanding 53.04
Days Sales Outstanding ranked lower than
66.08% of 227 companies
in the Medical Care industry.
Industry Max: 524.5, Med: 39.87, Min: 0.25
MD: 53.04
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 46.59, Med: 52.83, Max: 58.39
Current: 53.04
46.59
58.39
Days Payable 4.44
Days Payable ranked lower than
94.32% of 176 companies
in the Medical Care industry.
Industry Max: 1871.61, Med: 40.58, Min: 1
MD: 4.44
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 3.83, Med: 4.52, Max: 7.33
Current: 4.44
3.83
7.33

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate 1.60
3-Year Share Buyback Rate ranked higher than
86.16% of 159 companies
in the Medical Care industry.
Industry Max: 100, Med: -2.5, Min: -549.3
MD: 1.6
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -33.1, Med: 0.45, Max: 19.4
Current: 1.6
-33.1
19.4

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 0.32
Price-to-Intrinsic-Value-Projected-FCF ranked higher than
91.09% of 101 companies
in the Medical Care industry.
Industry Max: 20.14, Med: 1.98, Min: 0.07
MD: 0.32
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.32, Med: 0.98, Max: 3.84
Current: 0.32
0.32
3.84
Price-to-DCF (Earnings Based) 0.74
Price-to-Intrinsic-Value-DCF (Earnings Based) ranked higher than
75.76% of 33 companies
in the Medical Care industry.
Industry Max: 6.43, Med: 1.81, Min: 0.5
MD: 0.74
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
Price-to-Intrinsic-Value-DCF (Earnings Based) range over the past 10 years
Min: 0.32, Med: 0.77, Max: 1.27
Current: 0.74
0.32
1.27
Price-to-Median-PS-Value 0.31
Price-to-Median-PS-Value ranked higher than
82.21% of 208 companies
in the Medical Care industry.
Industry Max: 12, Med: 1.03, Min: 0.01
MD: 0.31
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.27, Med: 1.12, Max: 3.41
Current: 0.31
0.27
3.41
Earnings Yield (Joel Greenblatt) % 10.18
Earnings Yield (Greenblatt) ranked higher than
81.68% of 273 companies
in the Medical Care industry.
Industry Max: 94.34, Med: 3.61, Min: -217.39
MD: 10.18
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: 5.9, Med: 8.8, Max: 19.4
Current: 10.18
5.9
19.4
Forward Rate of Return (Yacktman) % 17.24
Forward Rate of Return ranked higher than
75.94% of 133 companies
in the Medical Care industry.
Industry Max: 868.48, Med: 9.1, Min: -81.77
MD: 17.24
Ranked among companies with meaningful Forward Rate of Return only.
Forward Rate of Return range over the past 10 years
Min: 14.2, Med: 19.1, Max: 27
Current: 17.24
14.2
27

More Statistics

Revenue (TTM) (Mil) $ 3,596.45
EPS (TTM) $ -0.57
Beta 1.11
Volatility % 32.59
52-Week Range $ 24.3 - 48.77
Shares Outstanding (Mil) 86.54

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 4
Positive ROA N
Positive CFROA Y
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy N
Higher Current Ratio yoy Y
Less Shares Outstanding yoy Y
Higher Gross Margin yoy N
Higher Asset Turnover yoy N